Not an SEC registrant

Exelan Pharmaceuticals INC

Customers

2 federal agencies

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$4.8M

FY2027 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 2

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $78.8M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$74.1M	FY 2025	1		75A50325F80014
OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 76282-0702-45); 10 CT. BLISTERS PACKS. Award 75A50325F80014 on USAspending.gov ↗ Largest of 1 awards in FY2025: $74.1M obligated
Department of Veterans Affairs Department of Veterans Affairs	$4.8M	FY 2027	3	$96.1M → $4.8M	36C24827N0053
LENALIDOMIDE Award 36C24827N0053 on USAspending.gov ↗ Largest of 3 awards in FY2027: $2.5M obligated

Alerts are coming

Get an email when Exelan Pharmaceuticals INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.